Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Pancreatic Neoplasms × romidepsin × Clear all

Phase

Phase 1 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma, T-Cell, Peripheral 7 Multiple Myeloma 4 Lymphoma, T-Cell 4 Lymphoma, Non-Hodgkin 4 Waldenstrom Macroglobulinemia 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Burkitt Lymphoma 3 Immunoblastic Lymphadenopathy 2 Hodgkin Disease 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Mycosis Fungoides 1 Lymphoma, Large-Cell, Immunoblastic 1 Leukemia, Hairy Cell 1 Intraocular Lymphoma 1 Inflammatory Breast Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Breast Neoplasms, Male 1

Interventions

Gemcitabine 96 130-nm albumin-bound paclitaxel 46 Albumin-Bound Paclitaxel 36 Oxaliplatin 27 Fluorouracil 26 Capecitabine 20 Taxes 19 Leucovorin 19 pembrolizumab 18 Cyclophosphamide 17 Irinotecan 16 Cetuximab 11 Bevacizumab 11 fludarabine 10 Nivolumab 10 Cisplatin 10 durvalumab 8 Radiotherapy 8 spartalizumab 7 aldesleukin 7 Erlotinib Hydrochloride 7 avelumab 6 Radiosurgery 6 Paclitaxel 6 Drug Therapy 6 irinotecan sucrosofate 5 folfirinox 5 Injections 5 ALT-803 5 dehydroftorafur 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04257448 2025-09-30

SEPION

GWT-TUD GmbH

Phase 1/2 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡